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Crystal Structure of the IL-10/IL-10R1 Complex
Reveals a Shared Receptor Binding Site
complex consisting of one IL-10 homodimer and two
IL-10R1 molecules as observed in the crystal structure
of the IFN- receptor complex (Walter et al., 1995; Thiel
Kristopher Josephson,1,2 Naomi J. Logsdon,1
and Mark R. Walter1,2,3
1 Center for Macromolecular Crystallography
et al., 2000). However, incubation of soluble IL-10R12 Department of Microbiology
with IL-10 generates a stable complex that consists ofUniversity of Alabama at Birmingham
two IL-10 homodimers and four sIL-10R1 (Tan et al.,Birmingham, Alabama 35294
1995).
IL-10R1 and IL-10R2 are members of the class-2 cyto-
kine receptor family that also includes receptors for IFN-,Summary
IFN- (IFNAR-1 and IFNAR-2), and IFN- (IFN-R1 and
IFN-R2), as well as for Tissue Factor (TF) (Bazan, 1990a,Interleukin 10 (IL-10) is a dimeric cytokine that plays
1990b). The extracellular domains of the class-2 recep-a central role in suppressing inflammatory responses.
tors are distinguished from the related class-1 receptorsThese activities are dependent on the interaction of
by unique cysteine sequence patterns and the absenceIL-10 with its high-affinity receptor (IL-10R1). This in-
of a WSXWS (where X is any amino acid) sequencetermediate complex must subsequently recruit the
motif. Based on crystal structures of IFN-R1 and TF,low-affinity IL-10R2 chain before cell signaling can
class-2 receptors are comprised of tandem fibronectinoccur. Here we report the 2.9 A˚ crystal structure of
type III (FBN-III) domains oriented at 120 to one an-IL-10 bound to a soluble form of IL-10R1 (sIL-10R1).
other (Walter et al., 1995; Harlos et al., 1994). In contrast,The complex consists of two IL-10s and four sIL-10R1
the related class-1 cytokine receptors typified by growthmolecules. Several residues in the IL-10/sIL-10R1 in-
hormone (GH) and erythropoietin (EPO) receptors dis-terface are conserved in all IL-10 homologs and their
play structurally similar domains oriented at 90 (dereceptors. The data suggests that formation of the
Vos et al., 1992; Livnah et al., 1996). Different domainactive IL-10 signaling complex occurs by a novel mo-
angles between class-1 and -2 receptors alter the acces-lecular recognition paradigm where IL-10R1 and IL-
sibility of the cytokine binding loops required for ligand10R2 both recognize the same binding site on IL-10.
recognition.
Open reading frames have been identified in the ge-Introduction
nomes of the Epstein-Barr virus (EBV) (Moore et al.,
1990), human cytomegalovirus (hCMV) (Kotenko et al.,Interleukin-10 (IL-10) is a pleiotropic cytokine that inhib-
2000), and the Orf poxvirus (Orf) (Fleming et al., 1997)its cell-mediated immune responses while enhancing
that encode proteins with 25%–85% sequence identityhumoral immunity (Moore et al., 2001). Its primary role
to IL-10. Despite considerable sequence variation, theis to suppress immune function by blocking the synthe-
viral IL-10s bind to IL-10R1 and IL-10R2 and displaysis of proinflammatory cytokines (e.g., IL-1, IL-6, IFN-,
biological profiles similar to cellular IL-10. More recently,and TNF-) in T cells, monocytes, and macrophages,
computer-based genome searches as well as traditionaland by inhibiting the expression of cell surface mole-
cloning methods have identified five new cellular IL-10cules involved in antigen presentation and costimula-
homologs that share 25% sequence identity with IL-tion. These biological activities suggest IL-10 may have
10: AK155 (Knappe et al., 2000), IL-19 (Gallagher et al.,utility in the treatment of autoimmune and inflammatory
2000), IL-20 (Blumberg et al., 2001), IL-22 (Dumoutier etdiseases.
al., 2000a, Xie et al., 2000), and MDA-7 (Jiang et al.,
IL-10 cellular responses require the sequential assem-
1996). Sequence identity of the viral and cellular proteins
bly of two different receptor chains (IL-10R1 and IL-10R2)
is sufficient to ensure that all molecules are structurally
on the cell surface (Liu et al., 1994; Kotenko et al., 1997). homologous to IL-10. Some of the cellular IL-10 homo-
Initially, IL-10 binds to IL-10R1 with high affinity (Kd35– logs have been assigned biological functions that in-
200 pM). This intermediate IL-10/IL-10R1 complex is clude regulation of epidermal differentiation (IL-20)
subsequently recognized through a low-affinity interac- (Blumberg et al., 2001), production of acute phase re-
tion with IL-10R2, resulting in an active signaling com- actants (IL-22) (Dumoutier et al., 2000b), and inhibition
plex that induces intracellular tyrosine phosphorylation of cell growth (MDA-7) (Jiang et al., 1996). Receptors
and activation of latent transcription factors (STATs). for IL-20 (IL-20R1, IL-20R2) and IL-22 (IL-22R, IL-10R2)
IL-10 is a symmetric homodimer that is topologically have been identified as members of the class-2 cytokine
similar to the structure of IFN- where each -helical receptor family. Like IL-10, IL-20 and IL-22 each require
domain is formed by intertwining  helices from two the formation of a heterodimeric receptor complex to
peptide chains (Walter and Nagabhushan, 1995; Zdanov elicit biological responses. Interestingly, IL-10R2 was
et al., 1995). The domains of IL-10 and IFN- exhibit an shown to be a common signaling component of the IL-
“IFN- fold” defined by a pronounced (60) bend in 10 and the IL-22 receptor complexes (Xie et al., 2000;
their C-terminal helices (helix F) that is encircled by a Kotenko et al., 2001).
flexible loop connecting helices A and B. The bivalency Here we report the 2.9 A˚ crystal structure of IL-10 in
of the IL-10 dimer suggested it would form a symmetric complex with the extracellular domain of its high-affinity
receptor (sIL-10R1). As previously observed in solution,
crystallographic symmetry generates a complex con-3 Correspondence: walter@uab.edu
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sisting of two IL-10 dimers and four sIL-10R1s. The do- tion, 110 A˚ separates the C-terminal ends of the two
receptors where they are predicted to enter the cellmains of sIL-10R1 are structurally most similar to IFN-
R1. However, sIL-10R1 displays an interdomain angle membrane.
In solution, IL-10 and sIL-10R1 form a complex thatof 90, similar to class-1 cytokine receptors, rather
than 120 as observed for the class-2 receptors IFN- contains two IL-10 dimers and four sIL-10R1 molecules
(Tan et al., 1995). The observed solution stoichiometryR1 and TF (Walter et al., 1995; Harlos et al., 1994).
Of the 27 IL-10 residues that contact sIL-10R1, 9 are is generated in the crystal by two 1:2 complexes sepa-
rated by one unit cell translation of 46 A˚ along the aconserved in all viral IL-10 sequences, and 3 of these 9
are conserved in the sequences of the cellular IL-10 axis (Figure 1B). Roughly perpendicular to the unit cell
translation, the two symmetric 1:2 complexes are offsethomologs and IFN-. The structure of the IFN-/sIFN-
R1 complex reveals that IFN-R1 makes almost identi- from one another by21 A˚. This results in the formation
of a site II interface where the N-terminal sIL-10R1 do-cal contacts with this conserved residue cluster on IFN-
(Walter et al., 1995). IL-10R1 and IFN-R1 residues that main (D1) from one complex interacts with IL-10 and
with the C-terminal domain (D2) of the receptor in thecontact the cluster are also conserved in the high- and
low-affinity receptors for IL-10, IFN-, and the IL-10 ho- other complex. Since the two 1:2 complexes are related
by a local two-fold axis, equivalent interactions occurmologs. For IL-10, this suggests a novel molecular rec-
ognition paradigm where IL-10R1 and IL-10R2 each bind on each side of the 2:4 complex.
to the sIL-10R1 binding site on IL-10. The recognition
of the same surface on IL-10 by two different receptors Structure of IL-10
is strikingly different from the GHR paradigm where two The structure of receptor-bound IL-10 is very similar to
identical receptors bind different surfaces of the hor- unbound IL-10. The orientation of the two domains in
mone (de Vos et al., 1992). The serendipitous formation bound IL-10 is 92, which falls within the range of values
of the 2:4 IL-10/sIL-10R1 complex observed in our crys- (89–100) observed for unbound cellular (2ilk [Zdanov
tals provides a plausible model of how this receptor et al., 1996] and 1inr [Walter and Nagabhushan, 1995])
recognition scheme may be used to form the biologically and viral IL-10 structures (1vlk [Zdanov et al., 1997]).
active IL-10/IL-10R1/IL-10R2 complex. Each domain consists of six  helices assembled from
two intertwined peptide chains, of which helices A, B,
C, and D are donated from one chain and helices E andResults
F from the two-fold related chain (Figure 2A). Compari-
son of the bound and unbound IL-10 domains revealsStructure Determination
For structural studies, the six N-linked glycosylation a conserved -helical core consisting of residues 23–37,
45–107, and 111–156 (root-mean-square deviationsites in sIL-10R1 were removed by Asn → Gln mutations
to create sIL-10R1Q6. Trigonal crystals of a complex [rmsd] of 0.6 A˚ for 119 C pairs), while the AB and DE
loops as well as the N and C termini are flexible and/orcomprising IL-10 (residues 1–160) and sIL-10R1Q6 (resi-
dues 1–214) were obtained from PEG-6000 solutions at adopt multiple conformations.
In the complex, IL-10 residues 17–22 at the N terminuspH 6.2. The crystals belong to the spacegroup P3212,
with one IL-10 peptide chain and one sIL-10R1Q6 in the of helix A and AB loop residues 38–44 adopt ordered
conformations that are similar to those observed in 2ilk.asymmetric unit. The structure of the IL-10/IL-10R1Q6
complex was solved by MAD phasing using Se-Met sub- The close agreement between bound IL-10 and 2ilk in
these regions may be the result of unique crystal con-stituted IL-10 and refined at 2.9 A˚ resolution to Rcryst and
Rfree values of 23.1% and 28.6%, respectively (Table 1). tacts in 2ilk that possibly mimic sIL-10R1 interactions
(Zdanov et al., 1997). However, for 1inr and 1vlk, deter-The final model contains residues 11–160 for IL-10, resi-
dues 2–206 for sIL-10R1Q6, and 21 water molecules. mined in a different spacegroup, the same residue seg-
ments are disordered or deviate from bound IL-10 byThree sIL-10R1Q6 residues (His-19, Arg-76, and Met-
196) were built in alternate side chain conformations. up to 9 A˚. Despite formation of the receptor complex,
IL-10 residues prior to Gly-17 as well as the adjacentThe overall stereochemistry of the model is good with
only IL-10 residues His-109 and Gln-132 falling in the DE loop (residues 106–111) and the C terminus remain
flexible with temperature factors 80 A˚2.disallowed region of the Ramachandran plot as deter-
mined by the program PROCHECK (Lakowski et al.,
1993). Structure of sIL-10R1
sIL-10R1 folds into two domains to form an L-shaped
structure with overall dimensions of 77 A˚  37 A˚  27 A˚The IL-10/IL-10R1 Complex
The IL-10 dimer is positioned on a crystallographic two- (Figure 2B). The topology of each domain is closely
related to FBN-III modules that form a sandwich fromfold axis where it binds two sIL-10R1 molecules to form
a 1:2 IL-10/sIL10R1 complex (Figure 1A). Thus, each two antiparallel  sheets comprised of  strands A, B,
E and G, F, C, C´ (Figure 2C). The N- (D1) and C-terminalsIL-10R1 binds the identical two-fold related surfaces
of IL-10 comprised of helix A, the AB loop, and helix F (D2) domains are comprised of residues 1–98 and 105–
205. The domains are connected by a six residue linker(site I interface) in a manner analogous to the complex
between IFN- and its high-affinity receptor, sIFN-R1 that forms one turn of 310-helix followed by a three resi-
due  strand ( strand L) that makes hydrogen bonds(Walter et al., 1995; Theil et al., 2000). To form this sym-
metric interaction with IL-10, sIL-10R1 makes an angle between  strand A of D1 and residues prior to  strand
G in D2. A similar linker interaction has been previouslyof 30 (versus 60 for sIFN-R1) with respect to the
putative position of the cell membrane. In this orienta- observed in the structure of GP130 (Bravo et al., 1998).
Crystal Structure of the IL-10 Receptor Complex
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Table 1. Data Collection, MAD Phasing, and Refinement Statistics
Data Collection
1 (“Edge”) 2 (“Peak”) 3 (“Remote”) NATIVE
Wavelength (A˚) 0.9779 0.9792 0.9184 0.9184
Resolution (A˚) 50–3 50–3 50–3 50–2.9
Number observations 42,974 43,317 45,470 24,449
Number unique 6,758 6,762 6,998 8,189
aRedundancy 6.4 (3.9) 6.4 (4.0) 6.5 (4.7) 2.8 (2.4)
Percent complete 84.6 (49.0) 84.6 (48.9) 88.0 (58.0) 92.8 (75.0)
I/ 8.2 (3.8) 8.4 (3.2) 8.1 (3.0) 9.1 (5.2)
bRsym 0.072 (0.212) 0.074 (0.232) 0.073 (0.250) 0.050 (0.122)
Ranom 0.027 0.035 0.028 —
Cell a,b (A˚) 46.12 46.23
c (A˚) 308.08 307.78
MAD Phasing
Resolution 50–3 A˚
Anomalous scatterers 6 Se atoms
f 	, f ″ 
9.7, 3.2 
7.5, 5.5 
1.8, 3.4
Phasing power 0.56/0.45 0.71/0.54 0.0/0.0
Figure of merit 0.31
Refinement Statistics
Resolution 50–2.9 A˚
Number of reflections Rwork (Rfree) 8,135 (571)
cRwork (Rfree) 23.1 (28.6)
dRmsd bonds (A˚) 0.008
Rmsd angles () 1.43
Number protein atoms 2,898
Number water molecules 21
Ramachandran plot quality
Most favored (%) 78.2
Additionally favored (%) 19.9
Generously allowed (%) 1.2
Disallowed (%) 0.6
a Parentheses denote statistics in the highest resolution shells. They are (3.1–3.0 A˚) for 1, 2, 3 and (2.97–2.90 A˚) for the native data.
b Rsym  (|I(i) 
 I(h)|)/(I(i)) where I(i) is the ith observation of the intensity of a reflection with indices h,k,l and I(h) is the average
intensity of all symmetry equivalent measurements of that reflection.
c Rwork  |Fobs(h)
 Fcalc(h)|/|Fobs(h)| where Fobs(h) and Fcalc(h) are the observed and calculated structure factor amplitudes, respectively.
Rfree is calculated as Rwork but for 5% of the data excluded from refinement.
d Rmsd in bond lengths and angles are the deviations from ideal values.
The linker interactions as well as a large hydrophobic drogen bonds to the amide nitrogen on  strand F (Ala-
81) as observed in the classic WSXWS motifs of class-1D1/D2 interface (1320 A˚2 of buried surface) constrain
the positions of the domains at approximately 90 with receptors, while Thr-91 forms a novel hydrogen bond
with the carbonyl oxygen of Pro-8 located prior to respect to one another. This unexpected 90 interdo-
main angle was previously thought to be restricted to strand A. This hydrogen bonding pattern results in two
modified widebulges (bulge 1 and bulge 2) that containclass-1 cytokine receptors, while class-2 receptors
would display 120 angles. Despite the large difference one (Asn-89) and three (Asn-94, Thr-95, Arg-96) bulged
residues, respectively. Bulge 2 positions the C-Cin interdomain angles between IL-10R1 and IFN-R1,
each receptor exposes the same five loops (L2-L6) for bond of Arg-96 approximately parallel, rather than per-
pendicular, to  strand G2 so that it can participate inligand binding.
sIL-10R1 D1 is structurally most similar to D1 of extensive interactions with IL-10 in the site I interface
(Figures 2D and 3A). Despite the lack of main chainIFNR1. Structural superposition revealed 81 equivalent
C atoms with a rmsd of 1.2 A˚ (compared against PDB hydrogen bonds, the side chain conformation of Arg-96
is restrained for ligand binding by a hydrogen bondcode 1fyh) (Randal and Kossiakoff, 2001). D1 contains
one novel disulfide bond that tethers Cys-35 in  strand between its N atom and the carbonyl oxygen of Asn-
73 located on the L3 loop. In addition to the  bulges,C to Cys-54 in  strand C	 in the same  sheet, rather
than  strands C	 and E located on opposite  sheets Trp-48 and Trp-90 participate in an extensive  cation
system by stacking between Arg-78 and Arg-80 of as observed in IFN-R1 and TF (Walter et al., 1995;
Harlos et al., 1994). The most notable feature of D1 is strand F. The location of the Trp residues at the end of
 sheets C	 and G2 suggests they may play an importanta “WSXWS-like” motif consisting of residues His-87,
Ser-88, Asn-89, Trp-90, and Thr-91 that divides  strand role in stabilizing the structures of the L2 and L4 loops
for ligand bindingG into two equivalent segments labeled G1 and G2.
Interestingly, only the side chain oxygen of Ser-88 hy- The importance of the D1 “WSXWS-like” motif for
Immunity
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Figure 1. Structure of the IL-10 Receptor
Complex
(A) Ribbon diagram of the 1:2 IL-10/sIL-10R1
complex viewed perpendicular to the two-
fold axis of IL-10.
(B) Ribbon diagram of the 2:4 IL-10/sIL-10R1
complex viewed down the two-fold axis of
IL-10. The box outlines the location of the site
IIa interface shown in Figure 3D.
ligand binding is underscored by its conserved structure consists of Lys-199, while the hydroxyl of Ser-198 hydro-
gen bonds to the main chain nitrogen of Val-184 on and function in IFN-R1, where bulge 2 contains only
two residues (Glu-103 and Glu-104; Figure 2D). Despite strand F. Residues 194–196 (Met-Gly-Lys) correspond-
ing to the WSX residues (WSXWS) of the classical motifthis difference, the C positions of Glu-104 in IFN-R1
differs from Arg-96 in IL-10R1 by only 0.9 A˚. Remarkably, form main chain hydrogen bonds with the domain linker
( strand L). Comparison of D2 from sIL-10R1 with GHRthe side chain conformation of Glu-104 is also restrained
for interaction with IFN- by an analogous hydrogen reveals C atom differences of more than 4 A˚ for the L6
loop. Thus, sequence differences in or near the WSXWSbond between the OD1 of Glu-104 and the O atom of
Ser-83 from L3 of the IFN-R1. region can drastically alter the secondary structure of
the receptor binding loops as well as the orientation ofD2 of sIL-10R1 is most similar to D2 of IFN-R1 where
71 equivalent C atoms were superimposed with a rmsd the D1/D2 domain interface.
of 1.6 A˚ (55 at 0.89 A˚). Despite a conserved  sandwich
core, D2 exhibits large structure and sequence differ-
ences with D2 from IFN-R1 that occur mainly in the The IL-10/IL10R1 Site I Interface
The site I interface is characterized by extensive interac-three loops located in the D1/D2 interface (L5, C	E loop,
L6). D2 contains one disulfide bond between Cys-181 tions between IL-10 and sIL-10R1 loops located at the
D1/D2 interface (Figures 2A and 2B). A total of 27 resi-and Cys-202 that links strand F and strand G of the same
 sheet. Prior to strand G, residues 197–200 (sequence dues from IL-10 make contact with sIL-10R1. Residues
are donated from two discontinuous peptide segmentsWSKE) forms a polyproline type II helix. In IL-10R1, Trp-
197 and Ser-198 are structurally equivalent to the sec- that correspond to helix A, the AB loop, and helix F. The
complementary receptor binding site is comprised ofond WS repeat (WSXWS) of the classical WSXWS motif
observed in class-1 receptors (Livnah et al., 1996). As 23 amino acids displayed on the five receptor segments
designated L2–L6. Contact residues identified in thea result, the helix gives rise to only one  bulge that
Crystal Structure of the IL-10 Receptor Complex
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Figure 2. Structure of IL-10 and sIL-10R1
(A) Site I on IL-10. For clarity, only one domain of the IL-10 dimer is shown. The peptide chain that includes helices A–D is cyan (residues
11–116), and the two-fold related chain containing helices E and F is yellow (residues 117–160). Site Ia residues are red and site Ib residues
are green.
(B) Ribbon diagram of sIL-10R1 bound to IL-10. For sIL-10R1,  strands are teal,  helices are blue, and 310 helices are cyan. Color scheme
for IL-10 is the same as Figure 2A. The “WSXWS-like” motif is located on the IL-10R1 by the sequence HSNWT.
(C) Schematic diagram of sIL-10R1. Secondary structure elements were calculated using DSSP as implemented in Ribbons (Carson, 1997).
 strands are shown as arrows and helices as boxes. Disulfide bonds are shown as thick black lines, and potential N-linked glycosylation
sites are shown as black circles. D1 receptor binding loops (L2, L3, L4) are red and D2 loops (L5 and L6) are green.
(D) Comparison of IL-10R1 and IFN-R1 D1  bulge 2 motifs. Motifs are shown in yellow for IL-10R1 and green for IFN-R1. Nitrogen and
oxygen atoms are shown in blue and red, respectively. Dashed lines represent hydrogen bonds.
structure are consistent with peptide mapping studies 43 buries the most surface area of any residue (105 A˚2)
into a shallow cavity created by helix F and the AB loop.of the IL-10/sIL-10R1 interface (Reineke et al., 1998).
The change in accessible surface area upon complex The base of the cavity is formed by Glu-142 and Lys-
138 that each form hydrogen bonds to the OH of Tyr-43.formation is 996 A˚2 and 1094 A˚2 for IL-10 and sIL-10R1,
respectively. Residues in the interface are mostly polar sIL-10R1 residue Arg-96 forms an extensive hydrogen
bond/salt bridge network with Asp-144, Gln-38, and(70%) and cluster into two structurally distinct interac-
tion surfaces, Ia and Ib. Site Ia is centered on the bend main chain carbonyl oxygen of Ser-141 from IL-10. Arg-
76 is observed in two conformations in the interface. Inin helix F and includes the AB loop, while site Ib is
located near the N terminus of helix A and the C terminus one conformation, it forms an ion pair with IL-10 Asp-
44 and a hydrogen bond with Gln-42. In its second con-of helix F. Receptor binding loops L2–L4 interact exclu-
sively with site Ia, while loops L5 and L6 in D2 interact formation, it forms a hydrogen bond to the main chain
oxygen of IL-10 residue Gln-38 and a water molecule.with site Ib.
Site Ia accounts for approximately 67% of the total Site Ib is centered on the ion pair between IL-10 resi-
dues Arg-27 and Glu-151 located on helices A and F,buried surface area in the site I interface. Although 17
receptor residues bury 5 A˚2 of surface area into site I, respectively (Figure 3B). An extensive hydrogen bond
network occurs between the side chain oxygens of Glu-only the side chains of Tyr-43, Arg-76, and Arg-96 make
extensive interactions in the interface (Figure 3A). As 151 and receptor residues Ser-190 and Arg-191 located
on the L6 loop. The carbonyl oxygens of Ser-190 andpreviously observed for IFN-R1, sIL-10R1 residue Tyr-
Immunity
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Figure 3. Molecular Details of the Site I and Site II Interfaces
(A) The site Ia interface. IL-10 residues are cyan and sIL-10R1 residues are gold. Oxygen atoms are red and nitrogen atoms are blue. Hydrogen
bonds are shown as dotted lines.
(B) The site Ib interface. Residues are colored as described in Figure 3A.
(C) Molecular surface of the site II interface. The surface of IL-10 is cyan and sIL-10R1 is yellow. The orientation of the figure is equivalent to
Figure 1A. Surfaces on IL-10 and sIL-10R1 that form the site IIa and IIb are shown in red and green, respectively. The adjacent 1:2 complex
is shown as a ribbon and colored as described in Figure 1B.
(D) Close-up of the site IIa interface. Color coding is as described in Figures 1B and 3A. Sites Ia, Ib, and IIa are labeled in parenthesis. The
box in Figure 1B shows the location of this Figure with respect to the 2:4 complex.
Arg-191 also form hydrogen bonds with the N atoms and DE loop of IL-10 (Ser-11, Thr-13, Asn-18, Arg-104,
Arg-107) for site IIa and  strands C and C	 (Glu-147,of Arg-27 and Arg-24, respectively. The interface also
Phe-159, His-161, Lys-163) of D2 for site IIb.contains a small hydrophobic surface comprised of re-
Site II is mostly comprised of van der Waals interac-ceptor residue Phe-143 that packs into a cleft formed
tions. Site IIa contains two IL-10/D1 residue pairs thatby IL-10 residues Pro-20 and Ile-158. Additional hy-
could potentially form specific interactions in the inter-drophobic surface area is donated to the interface
face, although the residues are separated by about 4 A˚through packing of the aliphatic portions of the sIL-10R1
in the structure (Figure 3D). Site IIb forms one hydrogenArg-191 and IL-10 Arg-27 side chains.
bond between Gln-53 on D1 and Glu-147 on D2 of the
adjacent complex. Although Gln-53 is an asparagine
The IL-10/sIL-10R1 Site II Interface residue in wild-type sIL-10R1 that is likely glycosylated,
The site II interface consists of interactions between D1 analytical gel filtration experiments show that heavily
from one 1:2 complex with IL-10 and D2 from the adja- glycosylated sIL-10R1 also forms a 2:4 complex in solu-
cent complex (Figures 1B and 3C). The total change in tion (Tan et al., 1995). Analysis of the electrostatic sur-
accessible surface area upon formation of the interface face of sIL-10R1 reveals several negatively charged
is 598 A˚2 (299 A˚2 for each two-fold related site II inter- patches near Gln-53 that may allow the N-linked sugar
face). Analysis of one site II interface reveals that like site residues to form weak interactions with the adjacent
I, site II is comprised of two distinct contact surfaces, IIa receptor in the 2:4 complex.
and IIb. Nine residues bury 5 A˚2 of surface area into Assembly of the 2:4 complex appears to be a sequen-
each side of the interface. Site IIa (residues 44–47) and tial process that depends on the initial formation of the
IIb (residues 51–54 and 56) are located on either end of site I interface (e.g., 1:2 complex). Specifically, L2 buries
 strand C	 in D1. The complementary contact surfaces surface area into site Ia (sIL-10R1 residues 41–48, in-
cluding Tyr-43) and IIa (sIL-10R1 residues 44–47) inter-on the adjacent 1:2 complex consist of the N terminus
Crystal Structure of the IL-10 Receptor Complex
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Figure 4. Sequence Conservation in the Site
I Interface
(A) Amino acid sequence of IL-10 residues
in the site I interface. Helices are shown by
brackets and labeled. IL-10 residues that bury
5 A˚2 of surface area in site I are colored
according to their degree of conservation in
the IL-10 family of proteins. Compared se-
quences are human IL-10 (Vieira et al., 1991),
ebvIL-10 (Moore et al., 1990), hcmvIL-10 (Ko-
tenko et al., 2000), orfIL-10 (Fleming et al.,
1997), ehv2IL-10 (Rode et al., 1994), IL-19
(Gallagher et al., 2000), IL-20 (Blumberg et al.,
2001), IL-22 (Xie et al., 2000), AK155 (Knappe
et al., 2000), and MDA-7 (Jiang et al., 1996).
Residues conserved in all sequences 10 of
10 or 9 of 10 are blue; 8 of 10, green; 7 of 10,
yellow; and 6 of 10, orange. Residues with
five or less conserved amino acids are red.
Residues not involved in interactions with IL-
10R1 are gray. The nine residues conserved
in all viral IL-10 homologs are denoted by
dots above the sequence. The three residues
conserved in IFN- are labeled with a “#.”
(B) IL-10 site I color coded by sequence con-
servation. IL-10R1 residues that make exten-
sive contacts with IL-10 (residues marked
with asterisks in Figure 4D) are shown as ball-
and-stick models where carbon atoms are
white, oxygen atoms are red, and nitrogen
atoms are blue. From left to right in the figure,
receptor residues shown are G44, Y43, R76,
R96, S190, and R191. The orientation of IL-
10 is identical to Figure 2A.
(C) IFN-R1 binding site on IFN-. Residues that bury 5 A˚2 of surface area upon contact with IFN-R1 are red or blue. The three residues
conserved between IL-10 and IFN- (IFN- residues Lys-12, Lys-108, and Glu-112) are blue. Residues not involved in IFN-R1 binding are
shown in gray. IFN-R1 residues that make extensive contacts with IFN- are shown in ball-and-stick models and colored as described in
Figure 4B except carbon atoms are yellow. Receptor residues shown (left to right) are G53, Y52, W85, E104, V209, and W210.
(D) Sequence alignment of the IL-10, IFN-, and IL-10 homolog receptor binding loops. IL-10R1 residues 41–48 (L2), 73–76 (L3), 92–101 (L4),
142–143 (L5), and 187–193 (L6) are aligned to equivalent IFN-R1 residues based on structure superposition. Additional alignments are shown
for IL-10R2 (Kotenko et al., 1997), IL-22R (Xie et al., 2000), IL-20R1 and IL-20R2 (Blumberg et al., 2001), and IFN-R2 (Soh et al., 1994).
Residues shown on Figures 4B and 4C are denoted with an asterisk. Receptor residues that bury surface area (5 A˚2) upon binding IL-10 or
IFN- are shaded yellow and cyan, respectively.
faces (Figures 1B and 3D). On the adjacent 1:2 complex, residues in a manner reminiscent of the “hot spot” identi-
fied in the growth hormone system where energeticallythe L5 loop inserts Phe-143 into a hydrophobic pocket
in the site Ib interface. This pocket is adjacent to Asn- important contacts are surrounded by less important
ones (Clackson and Wells, 1995). The expected comple-18, which forms part of the complementary IIa binding
surface on IL-10. The position of Asn-18 in the unbound mentary nature of the ligand and receptor binding hot
spots is consistent with the extensive hydrogen bondingIL-10 structures (1inr and 1vlk) is located near the Phe-
143 binding pocket 6 A˚ away from its position in the and salt bridge interactions made between the con-
served binding site and sIL-10R1 residues Tyr-43, Arg-2:4 complex. This suggests that upon sIL-10R1 binding
at site I, Phe-143 may induce a conformational change 96, Ser-190, and Arg-191 (Figures 3A and 3B).
A smaller cluster of four residues (Asp-41, Lys-138,in the N terminus of IL-10 helix A that results in a compe-
tent site IIa binding surface. Similar conformational Glu-142, and Asp-144) in the epitope are conserved in
all IL-10 homologs. A fifth residue, Lys-34, is conservedchanges may occur in the receptor L2 loop upon site I
binding. in all sequences except IL-20, which contains an Arg
residue. Three of these residues (IL-10 numbering Lys-
34, Lys-138, and Glu-142) are also conserved in IFN-Conserved Residues in the Site I Interface
(Figures 4A and 4C). IL-10 residues Lys-138 and Glu-Human IL-10 and several viral IL-10 homologs bind to
142 and IFN- residues Lys-108 and Glu-112 form aIL-10R1 and initiate similar cellular responses (Liu et al.,
conserved binding pocket for Tyr-43 in IL-10R1 and Tyr-1997). Comparison of IL-10 and viral IL-10 amino acid
52 in IFN-R1, respectively. The receptor tyrosines aresequences reveals nine conserved residues that partici-
located on L2 loops, where upon superposition of IL-pate in the IL-10/sIL-10R1 interface (Figure 4A). Six of
10R1 and IFN-R1 D1 domains, their C atoms differthe nine residues are found in site Ia, and three are found
by 2 A˚. Upon complex formation, the two tyrosines buryin site Ib. These nine amino acids form a conserved sIL-
the most surface area of any residues in their respective10R1 binding site in the center of site I (Figure 4B). The
binding surface is surrounded by less conserved contact binding pockets (105 A˚2 for Tyr-43 and 143 A˚2 for Tyr-
Immunity
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Figure 5. Comparison of IL-10 and IFN- Re-
ceptor Complexes
(A) Orientation of IL-10 and IFN- on their
receptors. The D1 domains of sIL-10R1 and
sIFN-R1 are superimposed as shown in Fig-
ure 5B. IL10R1 and IFN-R1 are shown as
green and cyan surfaces, respectively. For
clarity, only segments of IL-10 (purple) and
IFN- (blue) that contribute residues to the
interface are shown. The rotations required
to superimpose IL-10 on IFN- are shown on
the axes above the figure.
(B) Structural superposition of the D1 do-
mains of IL-10R1 and IFN-R1. Ribbons of IL-
10R1 and IFN-R1 are green and blue, respec-
tively. The five residues that make extensive
contacts with IL-10 (Tyr-43, Arg-76, Arg-96,
Ser-190, Arg-191) or IFN- (Tyr-52, Trp-85,
Glu-104, Val-209, Trp-210) are shown on the
receptors in purple and yellow, respectively.
52). Equivalent tyrosine residues have been identified in Trp-85 make contact with their respective ligands in a
similar location on the AB loop. Arg-76 in IL-10R1 formsall IL-10, IL-10 homolog, and IFN- receptor sequences,
suggesting that the conserved epitope is a common polar interactions with Asp-44 and Gln-38 on IL-10, while
Trp-85 forms a large van der Waals surface upon whichreceptor contact surface (Figure 4D).
the AB loop of IFN- rests (Figures 4B and 4C). In con-
trast, Arg-96 forms a salt bridge with Asp-144 on helixComparison of IL-10 and IFN- Receptor
F in IL-10, while Glu-104 interacts with conserved Lys-Binding Interfaces
12 on helix A in IFN-.IL-10R1 and IFN-R1 bind to similar surfaces on their
D2 residues Ser-190 and Arg-191 in IL-10R1 interactrespective ligands. However, when D1 of IL-10R1 and
with IL-10 site Ib, while Val-209 and Trp-210 in IFN-R1IFN-R1 are superimposed (rmsd 1.2 A˚), IL-10 must un-
contact an analogous site Ib in IFN- near Val-5 and Ile-dergo rotations of 23 and 9 and be translated by
0.7 A˚
114. Receptor contact sites (Ia and Ib) in IFN- and IL-10in X, 0.9 A˚ in Y, and 
2.9 A˚ in Z to superimpose upon
are 12 A˚ and 20 A˚ apart, respectively. To simultaneouslyIFN- (Figure 5A). The different orientations of IL-10 and
contact both sites, the receptors must change the dis-IFN- are largely the result of the interdomain angles of
tance and orientation of their receptor binding loops.their respective receptors (90 versus 120) that change
This occurs mostly through a change in D1/D2 domainthe positions of D2 and consequently the L6 binding
angles and large structural differences in the L6 looploops (Figure 5B). Comparison of the IL-10 and IFN-
conformations (Figure 5B). In contrast to the structurallyreceptor complexes suggests that the conserved tyro-
conserved residues on the D1 binding loops, superposi-sine residue found in L2 functions as a hook upon which
tion of receptor D2 domains reveals C atom differencesthe ligands hang. With the exception of this one con-
of 4.4 A˚ for the IL-10R1 Ser-190 and IFN-R1 Val-209served interaction, the remainder of the IL-10/sIL-10R1
residue pair, and 7.7 A˚ for the IL-10R1 Arg-191 and IFN-and IFN-/sIFN-R1 interfaces are structurally and
R1 Trp-210 pair.chemically diverse. These differences likely provide a
basis for the different specificity of the ligands.
Excluding the conserved tyrosine residues, four addi- Discussion
tional residues on IL-10R1 and IFN-R1 make extensive
contacts with their respective ligands and may be impor- IL-10R1 and IL-10R2 May Each Bind
to Site I on IL-10tant for high-affinity ligand binding. Two of the residues
are found in D1 and two are found in D2. Although dis- Despite considerable structural differences, IL-10 and
IFN- share a common fold (IFN- fold) that is definedplaying different amino acid side chains, the two resi-
dues in D1 are structurally conserved with Arg-76 and by a pronounced bend in helix F. Two residues (Lys-
138 and Glu-142 in IL-10) located at the bend in helix FArg-96 in IL-10R1 being equivalent to Trp-85 and Glu-
104 in IFN-R1 (Figures 2D and 4). When D1 of IL-10R1 are conserved in IL-10 and IFN- and form a binding
pocket for the receptor tyrosines located on L2 of theirand IFN-R1 are superimposed, C atom differences
for IL-10R1/IFN-R1 residue pairs Arg-76/Trp-85 and respective receptors (Figures 4 and 5). Since IL-10R2
also contains a conserved L2 tyrosine and is requiredArg-96/Glu-104 are 0.1 A˚ and 0.9 A˚, respectively. Despite
forming chemically different interactions, Arg-76 and for IL-10 cellular responses, we wondered whether IL-
Crystal Structure of the IL-10 Receptor Complex
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Figure 6. Model of the Biologically Active IL-10 Receptor Complex
The structures of the “intermediate” and “active” GH/GHR (left) and the modeled IL-10/IL-10R1/IL-10R2 (right) receptor complexes are
compared. GH requires a single receptor for cell signaling (GHR) while IL-10 requires two (IL-10R1 and IL-10R2). The initial high-affinity
interactions are made by the orange receptors (GHR and IL-10R1), and the subsequent low-affinity interactions are made by the yellow
receptors (GHR and IL-10R2). IL-10 receptor activation is thought to occur through the side-to-side association (the site II interface) of the
IL-10R1 and IL-10R2 chains. The putative position of the cell membrane is shown by a horizontal black line, and the receptor intracellular
domains are represented as ovals.
10R2 might also bind to the sIL-10R1 binding site. Struc- between Arg-151 (IL-10 Glu-151 → Arg) on IL-22 with
Asp-190 (IL-10R1 Ser-190 → Asp) in IL-10R2. The sec-ture-guided sequence alignments reveal three of the five
sIL-10R1 residues (Tyr-43, Arg-76, and Arg-191 using ond ion pair is especially significant since the Glu → Arg
substitution between IL-10 and IL-22 may replace anIL-10R1 numbering) that make extensive contacts with
IL-10 are conserved in the ligand binding loops of IL- unfavorable electrostatic (IL-10 Glu-151/IL-10R2 Asp-
190) repulsion in the IL-10/IL-10R2 complex with a new10R2 (Figure 4D). Consistent with the low affinity of IL-
10R2 for IL-10, Arg-96 is deleted from the L4 loop of salt bridge (IL-22 Arg-151/IL-10R2 Asp-190) in the IL-
22/IL-22R complex. The complementary chemistry andIL-10R2. These observations suggest that the high-affin-
ity IL-10R1 and low-affinity IL-10R2 may both interact location of these amino acid changes in the modeled
binding interfaces provide additional support that high-with the same conserved site I epitope on IL-10 (Fig-
ure 4B). and low-affinity receptors of IL-10, IFN-, and other IL-
10 homologs bind to the same surface on their respec-Furthermore, IL-10R2 was recently shown to be a
shared component of the IL-22 receptor complex (Xie tive ligands to form biologically active heterodimeric
receptor complexes.et al., 2000; Kotenko et al., 2000). Crosslinking studies
established that IL-22 exhibits an increased affinity for
IL-10R2 compared to IL-10. Consistent with this obser- A Model of the Biologically Active IL-10
Receptor Complexvation, two new salt bridges were identified in a model
of the IL22/IL-22R complex that were not observed in Assuming that IL-10R1 and IL-10R2 bind to the same
conserved epitope on IL-10, how would a biologicallya modeled IL-10/IL-10R2 complex. The first occurs be-
tween Arg-46 (IL-10 Leu-46 → Arg) on IL-22 and Asp-72 active receptor complex be formed? We propose that
the 2:4 IL-10 receptor complex is itself a model of the(IL-10R1 Ser-72 → Asp) on IL-10R2. The second occurs
Immunity
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29, 53, 89, 133, 156, 168) had been changed to glutamine residues.biologically active IL-10/IL-10R1/IL-10R2 complex where
The sIL-10R1Q6 was expressed in Drosophila S2 cells (Invitrogen)sIL-10R1 molecules in one 1:2 complex mimic the low-
and purified as previously described (Tan et al., 1995). IL-10 andaffinity IL-10R2 interaction with IL-10 (Figure 6). This
sIL-10R1Q6 were incubated at a 2:1 (sIL-10R1Q6: IL-10) molar ratio
model is constructed by simply replacing sIL-10R1s (red for 1 hr at 4C. The complex was purified by gel filtration and concen-
receptors in Figure 1B) in one complex with sIL-10R2 trated to 10 mg/ml for crystallization trials.
molecules. As described above, conserved residues in
the modeled IL-10/IL-10R2 interface support replacing Crystallization and Data Collection
Crystals of the IL-10/sIL-10R1Q6 complex were obtained at roomIL-10R1 with IL-10R2. Consistent with a need to bring
temperature by vapor diffusion using the hanging drop method.intracellular kinases together to initiate IL-10 signaling,
Purified IL-10/sIL-10R1Q6 complex in 20 mM Tris-HCL, 150 mMthe model places the membrane proximal regions of IL-
NaCl, and 2 mM Cymal-6 was mixed 1:1 with a well solution con-10R1 and IL-10R2 46 A˚ from one another rather than
sisting of 0.1 M ADA (pH 6.2), 8% PEG 6000, and 0.1 M MgCl2. X-ray
110 A˚ as observed for the two-fold related IL-10R1 re- diffraction data were collected at SSRL beamline 9-2 equipped with
ceptors. Thus, kinase activation by the complex would a Quantum-4 CCD detector. Data indexing revealed that the crystals
belong to spacegroup P3212 and contain one chain of IL-10 andoccur by IL-10R1 and IL-10R2 binding on one side of
one chain of sIL-10R1Q6 in the asymmetric unit. Crystals were cryo-the adjacent IL-10 dimers rather than across them. This
cooled, and K edge MAD data were collected at three wavelengthsis consistent with the ability of an engineered mono-
using inverse beam geometry from a single crystal of the SeMet IL-meric form of IL-10 to initiate biological responses (Jo-
10/IL-10R1Q6 complex (Table 1). Integrated and scaled intensities
sephson et al., 2000). Furthermore, the functional unit for each MAD dataset were obtained using DENZO, SCALEPACK,
of IFN- on cells has been determined to be comprised and SCALA processing software (Otwinowski and Minor, 1997). A
higher resolution native dataset was also collected and processedof two dimers supporting a similar model for the biologi-
using MOSFLM and SCALA (CCP4, 1994).cally active IFN-/IFN-R1/IFNR2 complex (Langer et
al., 1994).
Structure Determination and RefinementConformational changes between receptor bound
The location of IL-10 in the unit cell was obtained by molecularand free IL-10 suggested that formation of the 2:4 com-
replacement (MR) using the Amore program package and the pre-plex occurs by a sequential mechanism. This observa- viously determined structure of IL-10 as a probe (PDB code 1inr)
tion is also consistent with the sequential formation of (Navaza, 1994; Walter and Nagabhushan, 1995). Anomalous and
a biologically active complex where the initial IL-10/ dispersive difference Fouriers using the IL-10 MR phases identified
six of eight possible selenium positions in the SeMet IL-10/IL-IL-10R1 interaction creates a new surface (the site II
10R1Q6 complex data. Selenium positions corresponding to theinterface) that recruits IL-10R2. The low affinity of IL-
initiating methionine and Met-156 were not observed. MAD data10R2 for the IL-10/IL-10R1 complex suggests that some
were treated as a special case of MIR using E3 (remote) as thetype of preformed association of the receptors on the “native” and E1 (edge) and E2 (peak) as “derivatives” (Ramakrishnan
cell membrane must occur to allow formation of the and Viou, 1997). Interenergy scaling was performed using SCALA
active signaling complex. In the erythropoietin system, (CCP4, 1994), and phases were calculated with MLPHARE for all
data between 15 A˚ and 3 A˚. MAD phases were further improved bythe low affinity of EPOR for the EPO/EPOR complex is
solvent leveling, histogram matching, and skeletonization protocolsovercome by the formation of unliganded EPOR dimers
as implemented in DM (Cowtan and Main, 1998).on the cell surface (Livnah et al., 1999; Remy et al.,
Refinements were carried out using the maximum likelihood target1999). Interestingly, we have found that a soluble form function in CNS version 1.0 (Bru¨nger et al., 1998). Prior to refinement,
of IL-10R2 forms a noncovalent dimer in solution (B. 5% of the data were randomly omitted for monitoring Rfree (Bru¨nger,
Jones, N.L., and M.R.W., unpublished data). Thus, acti- 1992). Manual rebuilding sessions between cycles were done using
the graphics program CHAIN (Sack, 1988). Refinements includedvation of IL-10 signaling may occur by a scissoring
corrections for the bulk solvent and anisotropy in the diffractionmechanism as previously described in the erythropoie-
data (Jiang & Bru¨nger, 1994). All stages of the refinement weretin system (Livnah et al., 1999; Remy et al., 1999).
monitored by lowering of the Rfree, improvement in the geometry ofWe have presented compelling structural evidence the model using PROCHECK (Lakowski et al., 1993), and improve-
that IL-10R1 and IL-10R2 share the same binding site ment in the quality of the electron density maps. Model superposi-
on IL-10. This molecular recognition paradigm differs tions were performed manually using computer graphics and im-
proved by least squares (Kabsch, 1976). The RIBBONS programfrom the growth hormone system where two identical
suite was used for figure generation (Carson, 1997).receptors bind unique sites on the hormone to generate
an active signaling complex (de Vos et al., 1992; Figure
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